GRAND DESIGNInnovation Center For Industrial

Advanced Pharmaceuticals (ICIAPs)

YOGYAKARTA, AGUSTUS 4TH 2015

CONCEPT OF PHARMACEUTICAL INDUSTRIES DEVELOPMENT

INPUT OUTPUT OUTCOME

EXCELLENT HUMAN RESOURCES

QUALIFIED PHARMACEUTICAL PRODUCTS

VALID & ADVANCED MEDICAL DEVICES

RND INSTITUTIONS

UNIVERSITIES

MINISTRY OF RESEARCH

MINISTRY OF FINANCE

MINISTRY OF INDUSTRY

MINISTRY OF HEALTH

PHARMACEUTICAL INDUSTRIES

DEVELOPMENT OF INNOVATIVE

PHARMACUTICAL SCIENCE-TECH

HEALTH SERVICE

INNOVATIVE PHARMACUTICALS

PRODUCT

ADVANCED TECHNOLOGY VALUE

MODERN SOCIETY NEEDS

HIGH LEVEL of NATIONAL

COMPETITIVENESS

HIGH QUALITY OF HEALTH

STATUS

PROCESS

EFFECTIVE

EFFICIENT

POWERED PHARMACEUTICAL

INDUSTRIES

2

3

SWOT ANALYSIS

Strengths

Strong Networking

with Strategic

Institution

Track record of

UGM as World

Class University

Excellent Human

Resources

Opportunities

Innovative Product

Promising Market

Opportunities

Weaknesses

Uncompetitive

Indonesian

Pharmaceutical

Industries

Lack of the National

Research Fund

Lack of TRL-5 to

TRL-9 Facilities

Stagnancy of

Indonesian

Pharmaceutical

Research Downstream

Threat

Globalization

ASEAN

Harmonization

Lack of Potential

Indonesian Human

Resources

Invasion of Import

Innovative Product

ICIAPs RESOURCES

ICIAPs

MINISTRY OF RESEARCH

MINISTRY OF INDUSTRY

BATAN

LIPI

UGM ASSETSKIMIA FARMA

BIOFARMA

NAIST

4

KURRI

STELLA PHARMA & SUMITOMO HEAVY

INDUSTRY

RESOURCES OUTPUTPROCESS

TECHNOLOGY TRANSFER

DRUGS

BIOPHARMACEUTICALS

OUTPUT OF INNOVATION CENTER OF ADVANCED PHARMACEUTICALSUNIVERSITAS GADJAH MADA

PATENT

INTERNATIONAL PUBLICATION

GRADUATE STUDENT

ADVANCED PRODUCT

TRL 5-9

ICIAPs

PUBLIC POLICYFEEDBACK

GOVERNMENT POLICY

COSMETICS, PHYTOPHARMACA, NANOPHARMACEUTICALS

MINISTRY OF INDUSTRY

MINISTRY OF RESEARCH

BATAN

LIPI

UGM ASSETS

KIMIA FARMA

BIOFARMA

NAIST

PHARMACEUTICAL INDUSTRY READINESS

5

ROADMAP OF ICIAPs

TARGET 2015: TARGET 2016: TARGET 2017: TARGET 2018:

1. Rector Decree Issued forICIAPs OrganizationStructure

2. Ratification of MoU withMinistry of IndustryRepublic of Indonesia

3. Establishment of ICIAPsMaster Plan

4. Document Establishmentof Selected Pilot PlantProject

1.Setting up ICIAPs Construction:• The Building is settle,

tools and instruments are already available

2.Setting up Selected Pilot Plant Production• Establishment of

Validation and Qualification Plant

3.Screening of PotentialInnovative Pharmaceuticals Product• Profile of others

innovative pharmaceuticals product, cosmetics, phytopharmaca

1. Evaluation & Improvement of ICIAPs

2. Validation of Pilot Scale Production

3. Expansion of innovative advanced pharmaceuticals

1.Expansion of cooperation & networking:• Strengthening of

networking withadvanced pharmaceutical technology institution

2.Product Downstream3.Evaluation &

Improvement of ICIAPs4.Development of Pilot

Scale Production

STRENGTHENING THE NATIONAL INNOVATION SYSTEM ON THE FIELD OF MEDICAL AND PHARMACEUTICAL FOR NATION INDEPENDENCE BASED ON SCIENTECH ADVANTAGES

6

STRUCTURE OF ICIAPs

7

Director & Vice Director of ICIAPs

RnDDivision

University Sub Division

ADVISOR

RECTOR

Networking & Marketing Division

Biological Sub Division

Chemical Sub Division

Industry Sub Division

RnD Institution Sub Division

Chemical Analysis

Formulation and Scale

Up

Biological Synthesis

Effication& Safety

Organic Syntesis &

Preparation

Clinical Test

BiologicalAnalysis

NAIST COLLABORATION BENEFIT EXCHANGES

8

UGM

TECHNOLOGY TRANSFER

SCIENTIFIC MERIT EXPAND

STAFF/STUDENT EXCHANGE

INTERNATIONAL PUBLICATION

SUPERVISOR PATENT

THANK YOU